ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $307,000 | -24.9% | 6,987 | -15.7% | 0.05% | 0.0% |
| Q1 2021 | $409,000 | -24.4% | 8,286 | -35.5% | 0.05% | -23.9% |
| Q4 2020 | $541,000 | +14.4% | 12,854 | +24.4% | 0.07% | +18.3% |
| Q3 2020 | $473,000 | -11.3% | 10,332 | -2.6% | 0.06% | -11.8% |
| Q2 2020 | $533,000 | -57.6% | 10,611 | -56.6% | 0.07% | -59.3% |
| Q1 2020 | $1,257,000 | +383.5% | 24,432 | +479.6% | 0.17% | +288.4% |
| Q4 2019 | $260,000 | – | 4,215 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |